Dihydroartemisin-piperaquine

DRUG3 trials

Sponsors

Institute of Tropical Medicine, Belgium, Centre MURAZ/Institut National de Santé Publique, Strathmore University

Conditions

AnaemiaMalariaMalaria FalciparumMalaria InfectionMalnutrition in ChildrenSchistosomiasis in ChildrenSoil Transmitted Helminth (STH) Infections

Phase 3

Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru

CompletedNCT00373607

Institute of Tropical Medicine, BelgiumMalaria

Start: 2003-07-31End: 2005-07-31Updated: 2010-09-14

Unknown Phase

Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso

CompletedNCT06973200

Centre MURAZ/Institut National de Santé PubliqueAnaemia, Malaria Infection, Malnutrition in Children +2

Start: 2024-11-11End: 2025-02-25Updated: 2025-05-15

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

CompletedNCT07362498

Strathmore UniversityMalaria Falciparum

Start: 2020-06-01End: 2024-01-31Updated: 2026-01-23

Related Papers

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.

2007-10-3138 citations